Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Agarwal, Piyush K."" wg kryterium: Autor


Tytuł:
EFFICACY OF INTRAVESICAL NADOFARAGENE FIRADENOVEC FOR PATIENTS WITH BCG-UNRESPONSIVE CARCINOMA IN SITU OF THE BLADDER: 36-MONTH FOLLOW-UP FROM A PHASE 3 TRIAL.
Autorzy:
Boorjian, Stephen A. (AUTHOR)
Narayan, Vikram M. (AUTHOR)
Master, Viraj A. (AUTHOR)
Konety, Badrinath R. (AUTHOR)
Shore, Neal D. (AUTHOR)
Kamat, Ashish M. (AUTHOR)
Dinney, Colin P.N. (AUTHOR)
Bivalacqua, Trinity J. (AUTHOR)
Kates, Max R. (AUTHOR)
Montgomery, Jeffrey S. (AUTHOR)
Lerner, Seth P. (AUTHOR)
Crispen, Paul L. (AUTHOR)
Steinberg, Gary D. (AUTHOR)
Agarwal, Piyush K. (AUTHOR)
Schuckman, Anne K. (AUTHOR)
Svatek, Robert S. (AUTHOR)
Lane, Brian R. (AUTHOR)
Karsh, Lawrence I. (AUTHOR)
Bjurlin, Marc A. (AUTHOR)
Brown, Gordon A. (AUTHOR)
Pokaż więcej
Źródło:
Urologic Oncology. Mar2024:Supplement, Vol. 42, pS70-S70. 1p.
Czasopismo naukowe
Tytuł:
Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma-A Review.
Autorzy:
Walia AS; Department of Urology, University of California San Diego, La Jolla, CA 92093, USA.
Sweis RF; Department of Medicine, University of Chicago, Chicago, IL 60612, USA.
Agarwal PK; Department of Surgery, University of Chicago, Chicago, IL 60637, USA.
Kader AK; Department of Urology, University of California San Diego, La Jolla, CA 92093, USA.
Modi PK; Department of Surgery, University of Chicago, Chicago, IL 60637, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Dec 24; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 24.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
Autorzy:
Lee YH; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Lee MM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
De Silva DM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Roy A; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Wright CE; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Wong TK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Costello R; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Olaku O; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Grubb RL 3rd; Department of Urology, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Agarwal PK; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Bottaro DP; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 22; Vol. 16 (7), pp. e0241766. Date of Electronic Publication: 2021 Jul 22 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Autocrine Communication*
Receptor Protein-Tyrosine Kinases/*metabolism
Urinary Bladder Neoplasms/*pathology
Animals ; Cell Line, Tumor ; Databases, Factual ; Epithelial-Mesenchymal Transition/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Intercellular Signaling Peptides and Proteins/genetics ; Intercellular Signaling Peptides and Proteins/metabolism ; Kaplan-Meier Estimate ; Mice ; Neoplasm Invasiveness ; Protein-Tyrosine Kinases/genetics ; Protein-Tyrosine Kinases/metabolism ; Proto-Oncogene Proteins/antagonists & inhibitors ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism ; RNA Interference ; RNA, Small Interfering/metabolism ; Receptor Protein-Tyrosine Kinases/antagonists & inhibitors ; Receptor Protein-Tyrosine Kinases/genetics ; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/genetics ; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/metabolism ; Transplantation, Heterologous ; Urinary Bladder Neoplasms/metabolism ; Urinary Bladder Neoplasms/mortality ; Axl Receptor Tyrosine Kinase
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies